Joanna Breitstein

Joanna Breitstein is the executive editor of Pharmaceutical Executive.

From her start as a physician working in apartheid-era South Africa to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.

The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most.

Some say it's just another pharma facing its patent cliff. But others say this company's got it worse. With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?

Amgen's salvation just may be denosumab. We sit down to talk with the head scientists driving the drug.

The industry is a-changing. Here are eight seminal events that describe how.

In our first ever Emerging Leadership Awards, we profile 45 talented young professionals who will lead pharma into the next generation

Here's the saga of how market research, health outcomes, and dozens of other tools that connect the industry to patients came to be.

Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs

US officials think they can control MRSA and other "superbugs," but dangerous bacteria know no boundaries. What does the world do when its drugs stop working?